To investigate the tropism of the T-lymphotropic human herpesvirus 7 (HHV-7
) for hematopoietic progenitors, cord blood CD34(+) cells were inoculated i
n vitro with HHV-7 and then induced to differentiate along the granulocytic
and erythroid lineages by the addition of appropriate cytokine cocktails.
In semisolid assays, HHV-7 modestly affected the growth of committed (granu
locytic/macrophagic and erythroid) progenitors, whereas it significantly de
creased the number of pluripotent (granulocytic/erythroid/ monocytic/megaka
ryocytic) progenitors. Such inhibitory effect was completely abrogated by i
ncubating HHV-7 inoculum with anti-HHV-7 neutralizing serum. In liquid cult
ures, HHV-7 hastened maturation along the myeloid but not the erythroid lin
eage, as demonstrated by the up-regulation of CD33 early myeloid antigen at
day 7 of culture, and of CD15 and CD14 antigens at day 15. Moreover, HHV-7
messenger RNA was detected by reverse transcriptase-polymerase chain react
ion (RT-PCR) in cells maturating along both the myeloid and the erythroid l
ineages. To evaluate the relevance of these in vitro findings, the presence
of HHV-7 was investigated in bone marrow (BM) unfractionated mononuclear c
ells (MCs) as well as in purified CD34(+) and CD34(-) cell subsets, obtaine
d from 14 normal adult donors. HHV-7 DNA was detected by DNA-PCR In 4 of 7
BMMC samples, and it was found to be associated with both the CD34(-) (2 of
7) and the CD34(+) (1 of 7) fractions. These data indicate that HHV-7 infe
cts BM cells in vivo and shows the ability to affect the survival/different
iation of CD34(+) hematopoietic progenitors in vitro by inhibiting more anc
estral progenitors and perturbing the maturation of myeloid cells. (Blood.
2000;96:126-131) (C) 2000 by The American Society of Hematology.